Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI,LLC\'s market position
01-14
SHANGHAI,Jan. 11,2025-- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American:BQ) today announced that it will change its ratio of its American Depositary Shares ("A
01-13
TURFAN,China,Jan. 11,2025-- On January 9,2024,data released by Xinjiang Power Trading Centre Co.,Ltd. indicated that the green power trading electricity volume in the Turfan region reached 0.97 billio
01-13
CHENGDU,China,Jan. 11,2025-- SichuanKelun-Biotech Biopharmaceutical Co.,Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with t
01-13
LAS VEGAS,Jan. 11,2025-- UGREEN,a leading innovator in consumer electronics,made waves at CES 2025 with the unveiling of pioneering AI NAS solutions and other cutting-edge products. Under the launch e
01-13
HONG KONG,Jan. 11,2025-- On 9 January,Neusoft Education (09616.HK) announced that the Company\'s English name will change from "Neusoft Education Technology Co. Limited" to "Neutech Gro
01-13
TECNO launches an industry-first CMF technology that combines ultra-fine optical fibers with mini-LED lights into smartphone battery covers
01-11
TOKYO,Jan. 10,2025--TIER IV,the pioneering force behind the world\'s first open-source software for autonomous driving,has secured a permit for Level 4 operations in Shiojiri,Nagano Prefecture. This
01-11
LAS VEGAS,Jan. 10,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global cloud platform service provider,presented its cutting-edge innovations at CES 2025,which not only showcased numerous cutting-edge t
01-11
TOKYO,Jan. 10,2025--TIER IV,the pioneering force behind the world\'s first open-source software for autonomous driving,has secured a permit for Level 4 operations in Shiojiri,Nagano Prefecture. This
01-11
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
